Novel Anticoagulant Shows Superior Outcomes in Atrial Fibrillation
New anticoagulant demonstrates reduced stroke risk and fewer bleeding events compared to warfarin in AF patients.
Therapeutic Area: Cardiology
Heart and cardiovascular research